Talon Compounding Pharmacy Injectable MIC B Complex Sterility Recall
Talon Compounding Pharmacy is recalling MIC B Complex with Chromium/Methylcobalamin injectable (Lot 09022021:50) due to lack of assurance of sterility. The product was distributed across the United States, Washington D.C., and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable medication. The lack of assurance of sterility in an injectable product represents a direct risk of serious harm to patients, including infection and sepsis. Although no illnesses are reported in the source text, the hazard—non-sterile injectable—is inherent to the product category and poses significant risk without reported illness, meeting the High severity threshold.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling MIC B Complex with Chromium/Methylcobalamin injectable (4 vials, Lot 09022021:50, Beyond Use Date 12/01/2021) because there is a lack of assurance of sterility.
The product is a prescription injectable medication distributed across the United States, including Washington, D.C., and Puerto Rico. Compounded medications require confirmed sterility to ensure patient safety when administered.
Patients who have received this product should consult their healthcare provider. Healthcare providers who have dispensed this lot should immediately discontinue use and quarantine remaining units.
The recalled product
- Product
- MIC B COMPLEX W CHROMIUM/ METHYLCOB (BOYDEN) INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-failure
- injectable-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 09022021:50 BUD: 12/01/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27